Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RO1122
Host Cell : A549 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RO1122 |
| Description | This cell line is engineered to stably overexpress human VHL in A549 cells. |
| Target Gene | VHL |
| Gene Species | Homo sapiens (Human) |
| Host Cell | A549 |
| Host Cell Species | Homo sapiens (Human) |
| Applications |
1. Gene expression studies 2. Signaling pathway research 3. Drug screening and toxicology 4. Disease research |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | VHL von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase [ Homo sapiens ] |
| Gene Symbol | VHL |
| Synonyms | VHL; von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase; von Hippel Lindau syndrome , von Hippel Lindau tumor suppressor; von Hippel-Lindau disease tumor suppressor; VHL1; protein G7; elongin binding protein; RCA1; pVHL; HRCA1; |
| GeneID | 7428 |
| Uni ProtID | P40337 |
| mRNA Refseq | BC058831 |
| Chromosome Location | 3p25.3 |
| Function | enzyme binding; protein binding; transcription factor binding; |
| Pathway | Adaptive Immune System, organism-specific biosystem; Antigen processing: Ubiquitination and Proteasome degradation, organism-specific biosystem; Class I MHC mediated antigen processing & presentation, organism-specific biosystem; ECV complex, organism-specific biosystem; HIF-2-alpha transcription factor network, organism-specific biosystem; |
| MIM | 608537 |
The Human VHL Stable Cell Line, based on the A549 cell line, is designed to express the VHL (Von Hippel-Lindau) gene. VHL is a tumor suppressor gene that is crucial for regulating cell growth and preventing the formation of tumors. It functions by targeting specific proteins for degradation via the ubiquitin-proteasome system. Mutations in the VHL gene are associated with Von Hippel-Lindau disease, a hereditary condition that increases the risk of developing certain types of cancer, including renal cell carcinoma and hemangioblastoma. The A549 cell line, which is derived from a human lung carcinoma, is used for its ability to model the effects of VHL mutations in cancer. This stable cell line is instrumental for research into the mechanisms of VHL-mediated tumor suppression and for the development of targeted therapies for VHL-related cancers.
The Human VHL Stable Cell Line - A549 is instrumental for research into the VHL gene and its implications in cancer and other diseases. Its applications include:
(1) Tumor Suppression Mechanisms: VHL is a well-known tumor suppressor gene. This cell line can be used to study how VHL regulates cell growth and prevents tumor formation, providing insights into the molecular pathways that maintain cellular homeostasis.
(2) Cancer Therapy Development: Mutations in VHL are associated with Von Hippel-Lindau disease and certain cancers. Researchers can use this cell line to develop and test therapies that target VHL-dependent pathways, aiming to restore normal VHL function or compensate for its loss in cancer cells.
(3) Drug Resistance Studies: The A549 cell line can be used to investigate the mechanisms of drug resistance in cancer cells, as VHL''s role in protein degradation can influence the response to chemotherapeutic agents. Understanding these mechanisms can help in the development of strategies to overcome drug resistance.
A: This cell line, by stably expressing the VHL gene, provides a controllable experimental model for studying how the VHL protein functions as a tumor suppressor, helping to reveal key mechanisms of VHL in regulating cell proliferation, apoptosis, and hypoxia response.
A: By culturing A549 cells under hypoxic conditions, researchers can observe the impact of VHL gene expression on HIF stability and activity, thereby understanding the role of VHL in the hypoxia signaling pathway.
A: This cell line can be used to evaluate the effects of potential therapeutic compounds on VHL function, especially in VHL-related diseases such as Von Hippel-Lindau disease, aiding in the screening of drugs that can restore normal VHL function.
A: By monitoring the relationship between VHL expression levels and cell cycle progression, researchers can explore the role of VHL in cell cycle regulation, including its effects on cyclins and cyclin-dependent kinases.
A: This cell line can be used to study the role of the VHL gene in regulating apoptosis, especially the changes in apoptotic pathways when VHL function is lost.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
The Human VHL Stable Cell Line - A549 uses precise genetic engineering techniques to stably express the VHL gene in A549 cells, providing a highly controlled environment for studying the function of VHL protein.
By utilizing the Human VHL Stable Cell Line - A549, researchers can better understand the role of the VHL gene in the initiation and progression of tumors, aiding in the development of targeted cancer treatment strategies.
This product ensures stable expression of the VHL gene in A549 cells, guaranteeing high reproducibility of experimental results, which is crucial for scientific research.
Due to the importance of the VHL gene in various biological processes, the Human VHL Stable Cell Line - A549 is suitable for a wide range of research fields, including cancer research, cell biology, and drug screening.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.